Shaheen Shagufta
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors (NCT01525082) | Shaheen Shagufta | 2012-12-01 |
Track Shaheen Shagufta automatically
Every clearance here is in the API, with alerts when new ones post.